Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

1.4k indexed citations
published 2003

Countries where authors are citing Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

Specialization
Citations

This map shows the geographic impact of Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation more than expected).

Fields of papers citing Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation.

About Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation

This paper, published in 2003, received 1.4k indexed citations . Written by Jack H. Crawford, Rakesh P. Patel, Christopher D. Reiter, Sabrina Martyr, Benjamin Yang, Myron A. Waclawiw, Gloria Zalos, Xiuli Xu, Kris T. Huang and Howard Shields covering the research area of Physiology, Cell Biology and Endocrine and Autonomic Systems. It is primarily cited by scholars working on Physiology (981 citations), Cell Biology (362 citations) and Cardiology and Cardiovascular Medicine (326 citations). Published in Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm954.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Nuevos modelos de negocios en los mercados emergentesBreakdown of academic impact, for the paper The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 studyBreakdown of academic impact, for the paper Exercise Standards for Testing and TrainingBreakdown of academic impact, for the paper Disruption of IRS-2 causes type 2 diabetes in miceBreakdown of academic impact, for the paper Going deeper than microscopy: the optical imaging frontier in biologyBreakdown of academic impact, for the paper Exposure to pesticides and the associated human health effectsBreakdown of academic impact, for the paper A systematic review of evidence for the added benefits to health of exposure to natural environmentsBreakdown of academic impact, for the paper Cerebrospinal fluid and plasma biomarkers in Alzheimer diseaseBreakdown of academic impact, for the paper Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humansBreakdown of academic impact, for the paper Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
Rankless by CCL
2026